Bio-Techne Corp

TECH

Company Profile

  • Business description

    Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

  • Contact

    614 McKinley Place N.E.
    MinneapolisMN55413
    USA

    T: +1 612 379-8854

    https://www.bio-techne.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2027

    Employees

    3,000

Stocks News & Analysis

stocks

5 star fully franked ASX dividend payer

Investors in cheap ASX share with a narrow moat enjoys a high yield, but there are risks investors should be aware of.
stocks

An undervalued stock to buy that even Warren Buffett likes

Trading at an 18% discount, this wide-moat stock is a rare find.
stocks

ASX REIT downgraded following underwhelming exit

Discounted exit raises investor concerns.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,886.6035.900.41%
CAC 408,035.8742.61-0.53%
DAX 4025,399.2124.790.10%
Dow JONES (US)51,365.85115.66-0.22%
FTSE 10010,636.7148.17-0.45%
HKSE24,523.57118.94-0.48%
NASDAQ26,811.638.75-0.03%
Nikkei 22565,481.27396.35-0.60%
NZX 50 Index13,683.63147.05-1.06%
S&P 5007,674.728.97-0.12%
S&P/ASX 2008,709.3029.600.34%
SSE Composite Index3,830.456.830.18%

Market Movers